Skip to main content
. 2011 Jun 19;2011:385780. doi: 10.1155/2011/385780

Figure 3.

Figure 3

(a) Flavocoxid (0, 0.1, 1, 10, 50 μg/mL) COX-1 (□) and COX-2 (○) cyclooxygenase (CO) inhibition versus indomethacin (0, 3.6, 18, 36, 180, 360 ng/mL, ♦) and NS-398 (0, 3.1, 15.7, 31.4, 157, 314 ng/mL, ▲). (b) Flavocoxid (0.1, 0.5, 1, 2, 5, 10, 50, 100, 500 μg/mL) COX-1 (■) and COX-2 (□) peroxidase (PO) inhibition. (c) Inhibition of 5-Lipoxygenase for phenidone (●), baicalin (♦), flavocoxid (■), catechin (⋄), ibuprofen (+), and celecoxib (□) at 0.1, 0.2, 0.5, 1, 5, 10, 50, 100, 500 μg/mL.